AST/ALT (De Ritis) Ratio: What the Pattern Reveals About Liver Injury

What the De Ritis (AST/ALT) ratio actually is

The De Ritis ratio divides AST by ALT — two enzymes that leak into blood when liver cells are stressed or injured. ALT lives mostly in liver cells, making it more liver-specific. AST is found in the liver too, but also in heart, skeletal muscle, kidneys, and red blood cells, so it can rise for non-liver reasons. Fernando De Ritis described the ratio in 1957 in Minerva Medica, classically using it to distinguish hepatocellular from alcoholic liver injury. Population studies have since linked higher ratios with more advanced fibrosis and liver outcomes.

Why two liver enzymes read together name the injury

ALT sits mostly in the liver's cytosol. When hepatocytes are irritated by fat accumulation, insulin resistance, or viral hepatitis, ALT often climbs higher than AST — a cytosolic, hepatocellular signal. AST exists in both the cytosol and the mitochondria of liver cells, and also in skeletal muscle and heart tissue. Because of that dual compartment and multi-tissue origin, the ratio reveals where the injury pattern is coming from in a way that neither enzyme alone can show.

Alcohol-related injury illustrates this clearly. Alcohol disrupts mitochondrial function, releasing mitochondrial AST disproportionately. It also depletes pyridoxal-5'-phosphate (vitamin B6), a cofactor required for ALT synthesis — suppressing ALT relative to AST and producing the classically elevated ratio seen in alcohol-associated hepatitis. Metabolic liver disease follows the opposite logic: fat accumulation and insulin resistance drive cytosolic ALT release selectively, keeping the ratio below 1. Neither pattern is visible from a single enzyme value.

How the De Ritis ratio is calculated

De Ritis Ratio = AST (U/L) ÷ ALT (U/L)

Both values use the same unit (U/L); the result is unitless. No fasting is required — AST and ALT are not significantly affected by meals. One important pre-analytical note: hemolysis in the blood sample artificially elevates AST, because red blood cells contain AST. A hemolyzed specimen should be flagged and the draw repeated before acting on the result.

Different lab platforms use slightly different reference ranges for AST and ALT, so a ratio near 1 in one lab may not equal exactly 1 in another. The ratio is most meaningful when trended within the same laboratory.

Worked examples:

• AST 28 U/L ÷ ALT 42 U/L = 0.67 — an ALT-predominant pattern typical of early metabolic liver disease (NAFLD), where hepatocellular irritation from fat accumulation selectively raises ALT.
• AST 68 U/L ÷ ALT 30 U/L = 2.27 — an AST-dominant pattern consistent with the classical >2 De Ritis finding in alcohol-associated hepatitis, where mitochondrial AST release and B6 depletion suppress ALT.

Reading your AST/ALT number against the pattern

There is no single universal cutoff for the De Ritis ratio the way there is for sodium or hemoglobin. Many healthy people sit near a ratio of 1, but age, sex, body composition, training status, and the specific lab platform all shift that baseline. The ratio is most useful as a pattern indicator interpreted alongside absolute enzyme levels and other markers — not as a standalone verdict. Common patterns by range:

• Ratio <1 (ALT predominant): typical of metabolic dysfunction–associated steatotic liver disease (NAFLD/MASLD) and acute viral hepatitis, where cytosolic ALT release predominates. A low ratio does not equal low severity — a substantially elevated ALT with a ratio below 1 still signals active hepatocellular stress.
• Ratio 1–2 (borderline): a mixed or transitional pattern; seen across a range of conditions and not specific on its own. Context from companion tests is essential.
• Ratio >2 (AST dominant): the classical finding in alcohol-associated hepatitis, particularly when absolute enzyme levels are modest rather than markedly elevated; also seen in advanced fibrosis and cirrhosis, where hepatocytes are progressively replaced by fibrous tissue and enzyme distribution shifts toward AST dominance.

Two confounds deserve explicit attention. First, skeletal muscle contains AST — intense exercise or muscle injury raises AST without raising ALT, temporarily pushing the ratio above 1 without any liver pathology. Creatine kinase (CK) helps distinguish this. Second, a hemolyzed specimen artificially elevates AST; always confirm a high ratio on a clean draw. The ratio is a pattern indicator, not a diagnosis.

What shifts the De Ritis ratio

Several distinct mechanisms move the ratio in predictable directions:

• Alcohol and mitochondrial AST: alcohol disrupts mitochondrial function, releasing mitochondrial AST disproportionately. It also depletes pyridoxal-5'-phosphate (B6), a cofactor for ALT synthesis, suppressing ALT relative to AST. The combined effect pushes the ratio above 2 in alcohol-associated hepatitis.
• Metabolic liver disease and hepatocellular ALT predominance: fat accumulation and insulin resistance drive cytosolic ALT release selectively, keeping the ratio below 1. As liver fat recedes with improved metabolic control, ALT typically falls and the ratio may normalize.
• Muscle as a confounding AST source: skeletal muscle contains AST. Intense exercise or muscle injury raises AST without raising ALT, temporarily pushing the ratio above 1. This is physiology, not pathology. Creatine kinase helps distinguish a muscle-driven AST rise from a hepatic one.
• Advanced fibrosis and cirrhosis: as hepatocytes are replaced by fibrous tissue, enzyme distribution shifts toward AST dominance, gradually elevating the ratio even in the absence of acute alcohol exposure.
• Other clinical factors: choline participates in exporting fat from the liver as VLDL; inadequate intake can promote steatosis. Omega-3 fats have been shown to reduce liver fat content in some trials, with modest effects on enzymes. Coffee shows up consistently in observational research as liver-friendly, linked to lower fibrosis risk. Medications — including statins, antibiotics, anti-seizure drugs, anti-tubercular agents, and acetaminophen — can affect both enzymes. Thyroid disorders, celiac disease, and muscle disorders can alter AST and ALT patterns independently of liver injury.

The liver panel that frames AST/ALT

• Aspartate aminotransferase (AST) — the numerator; the standalone AST trend and absolute elevation level contextualize whether the ratio reflects active liver injury or post-exercise physiology.
• Alanine aminotransferase (ALT) — the denominator; ALT is the liver-specific reference point; its trend confirms whether the ratio is driven by ALT falling (B6 depletion / alcohol) or AST rising disproportionately.
• Gamma-glutamyl transferase (GGT) — GGT elevation alongside a high De Ritis ratio reinforces an alcohol-related or cholestatic pattern; GGT alone is more sensitive to alcohol than either AST or ALT.
• Albumin — the liver's protein-synthesis capacity; a falling albumin alongside an elevated ratio signals functional impairment beyond just enzyme leakage.
• Alkaline phosphatase (ALP) — elevated ALP with a high ratio leans toward biliary or cholestatic rather than pure hepatocellular injury; ALP and GGT together clarify bile-duct involvement.

A realistic retest window for the De Ritis ratio

Both AST and ALT respond to hepatic stressors within weeks. ALT typically normalizes within 4–8 weeks of alcohol cessation or a weight-loss intervention. AST may resolve within the same window, though mitochondrial recovery after alcohol injury can take slightly longer. Pace a retest at 8–12 weeks after an intervention to capture both enzyme trajectories fully.

For exercise-induced AST elevation, the timeline is much shorter — retest after 3–5 days of rest, as exercise-derived AST normalizes quickly. If muscle confounding is suspected, check creatine kinase at the same draw.

Same-lab testing is preferred: AST and ALT assay calibration varies across platforms, making within-lab comparison more reliable for detecting real change versus analytical noise.

When the AST/ALT ratio warrants hepatology follow-up

A ratio persistently above 2, particularly when accompanied by elevated GGT, rising bilirubin, a prolonged INR, falling albumin, or a declining platelet count, warrants prompt hepatology evaluation. These combinations suggest the liver may be moving beyond enzyme leakage into functional impairment — a distinction that changes clinical urgency. Noninvasive fibrosis scores such as FIB-4 (which combines age, AST, ALT, and platelets) can help stratify risk for advanced fibrosis; imaging such as ultrasound or elastography adds structural detail.

A ratio below 1 with a substantially elevated ALT also deserves follow-up, even though the pattern is less dramatic — active hepatocellular stress in metabolic liver disease can progress silently. Tracking the ratio alongside absolute enzyme levels, symptoms, and functional markers over months turns a single number into a trendline, enabling earlier course correction long before symptoms force the issue.

The De Ritis ratio is a small calculation with outsized context. Paired with the full liver panel, it transforms abstract numbers into a coherent narrative about injury pattern, functional reserve, and trajectory. At Superpower, that kind of integrated, longitudinal view is central to the approach — using evidence to move beyond population averages and toward decisions that fit your biology, your goals, and your life.